Astrazeneca Pharma India up on plans to launch breast cancer drug in Jan

Astrazeneca Pharma India

21/12/2023 04:24

** Shares of Astrazeneca Pharma India  ASTR.NS  rise as much
as 6.2% to 4900 rupees, marking their biggest one day gain since
August
    ** Co to launch breast cancer drug Enhertu in January in
India 
    ** Stock rises above its 50-day moving average after staying
below for the last four sessions; stock above its 100-, and
200-day moving averages since May
    ** More than 22,724 shares change hands, 2.4x the 30-day avg
    ** Stock last up 2.2%, extending YTD gains to 43%


 (Reporting by Dimpal Gulwani)
 ((dimpal.gulwani@thomsonreuters.com))